Clair, a startup founded by Stanford graduates, is developing a wearable hormone-tracking device to improve how women access and understand their hormonal health. The company, started by Jenny Duan ...

Irvine-based Masimo, which was acquired by Danaher, has received FDA clearance for a monitor feature to detect opioid-induced ...

"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

This popular CGM can now be marketed for children 2 years of age and older who do not use insulin. Anna Gragert Senior Editor, Health and Home Anna Gragert (she/her/hers) was previously the lifestyle ...

Share on Pinterest The FDA approved the first nonprescription sale of Dexcom’s continuous glucose monitor for children ages 2 to 18 with diabetes. Svetikd/Getty Images The Food and Drug Administration ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A major challenge in continuous fetal monitoring is that both the fetus and the umbilical cord are constantly moving. To address this, the researchers developed autonomous tracking algorithms that ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

Policy makers may be able to find middle ground in policies that, rather than eliminating prior authorization completely, put in place guardrails for their use to ensure patients still have access to ...

However, A1C isn’t your only option for tracking your blood sugar levels: Continuous glucose monitors (CGMs) have moved beyond type 1 diabetes care to being an important tool for type 2 management as ...

is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...

Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...